November 3, 2022 | Lauren Woods - Schools of Medicine and Dental Medicine

UConn’s Greg Rhee Named Fellow of American College of Epidemiology

Rhee's ACE fellow election is in honor of his significant contributions to the field epidemiology.

Greg Rhee, Ph.D., of the Department of Public Health Sciences at UConn School of Medicine.

The American College of Epidemiology (ACE) has named Greg Rhee, Ph.D., of UConn School of Medicine a Fellow of the College.

Rhee serves as assistant professor in the Department of Public Health Sciences at UConn Health.

His election as an ACE fellow is in high recognition of his significant and sustained contributions in epidemiology.

“Congratulations and welcome to the College,” shared ACE President Jan Eberth with Rhee in the recognition letter received with a certificate in recognition of Rhee’s election for his professional standing in the field of epidemiology.

Rhee is an interdisciplinary pharmaco-epidemiologist and health services researcher in the fields of aging and mental health. His current research interests are interrelated and consist of mood disorders, dementias, and suicidality as well as cannabis and opioids. Methodologically, his expertise is grounded in population-based comparative effectiveness and cost-effectiveness research using large databases and also systematic reviews and meta-analyses of existing studies. In particular, he has expertise in the use of national health and health care survey data (e.g., Health and Retirement Study and National Health and Nutrition Examination Survey), and federal or state-level administrative claims data (e.g., Medicare and Medicaid).

He has over 130 peer-reviewed research articles in leading medical, psychiatric, and health policy journals, such as American Journal of Psychiatry, JAMA Internal Medicine, and JAMA Psychiatry. His work has also appeared in New York Times, Washington Post, and U.S. News.

In addition, he is the founding director of the Mood Disorders and Aging-related Research Program (MDARP) housed in the Department of Public Health Sciences at UConn. He has been a successful principal investigator or co-investigator on multiple research projects funded by major federal agencies, including Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA), and National Institutes of Health (NIH). He is an alumnus of the University of Chicago and Yale University. He also holds an appointment in the Yale Department of Psychiatry.